Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced / Metastatic Solid Tumors

This study is an open-label Phase 1 / Phase 2 evaluation of INCB001158 as a single agent and in combination with immune checkpoint therapy in patients with advanced / metastatic solid tumors.
Not Available
I
Gibson, Mike
NCT02903914
VICCPHI1841

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: